Opsens (TSE:OPS) Stock Rating Reaffirmed by Royal Bank of Canada

Share on StockTwits

Opsens (TSE:OPS)‘s stock had its “outperform” rating reissued by Royal Bank of Canada in a note issued to investors on Thursday, Stock Target Advisor reports. They presently have a C$2.00 price objective on the stock. Royal Bank of Canada’s target price would suggest a potential upside of 6.95% from the company’s previous close.

Separately, Raymond James reissued an “outperform” rating and set a C$2.50 target price on shares of Opsens in a report on Monday, February 1st.

Shares of OPS stock traded up C$0.02 on Thursday, hitting C$1.87. 66,598 shares of the stock were exchanged, compared to its average volume of 231,599. The firm’s 50 day moving average is C$1.72 and its two-hundred day moving average is C$1.31. Opsens has a one year low of C$0.55 and a one year high of C$2.36. The firm has a market capitalization of C$198.93 million and a PE ratio of -930.00. The company has a current ratio of 3.60, a quick ratio of 2.45 and a debt-to-equity ratio of 82.37.

Opsens (TSE:OPS) last issued its earnings results on Wednesday, January 13th. The company reported C$0.01 earnings per share for the quarter. The business had revenue of C$8.34 million for the quarter, compared to the consensus estimate of C$8.30 million. On average, sell-side analysts expect that Opsens will post 0.06 earnings per share for the current year.

Opsens Company Profile

Opsens Inc develops, manufactures, installs, and sells fiber optic sensors for interventional cardiology, fractional flow reserve (FFR), oil and gas, and industrial applications. The company operates in two segments, Medical and Industrial. The Medical segment primarily focuses on physiological measurement, such as FFR and dPR in the coronary artery stenosis market; and supplies a range of miniature optical sensors to measure pressure and temperature used in integrated applications in other medical devices, as well as licenses its optical sensor technology.

Featured Article: Understanding Average Daily Trade Volume

Stock Target Advisor

Receive News & Ratings for Opsens Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Opsens and related companies with MarketBeat.com's FREE daily email newsletter.